Exploration of Targeted Anti-tumor Therapy

Open Access Original Article

Artificial intelligence fusion for predicting survival of rectal cancer patients using immunohistochemical expression of Ras homolog family member B in biopsy

Tuan D. Pham ... Xiao-Feng Sun

Published: February 07, 2023 Explor Target Antitumor Ther. 2023;4:1–16

DOI: https://doi.org/10.37349/etat.2023.00119

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

4457 45 10

Open Access Review

New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme

Manisha Singh ... Rachana

Published: December 30, 2022 Explor Target Antitumor Ther. 2022;3:866–888

DOI: https://doi.org/10.37349/etat.2022.00118

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

6323 71 1

Open Access Original Article

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

Flora Doffe ... Pierre Savagner

Published: December 29, 2022 Explor Target Antitumor Ther. 2022;3:853–865

DOI: https://doi.org/10.37349/etat.2022.00117

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

6146 143 3

Open Access Commentary

De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue

Danila Coradini

Published: December 28, 2022 Explor Target Antitumor Ther. 2022;3:841–852

DOI: https://doi.org/10.37349/etat.2022.00116

Full Text PDF

5462 37 8

Open Access Original Article

Dendritic cell-targeting chemokines inhibit colorectal cancer progression

Pengkun Yuan ... Bin Ma

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:828–840

DOI: https://doi.org/10.37349/etat.2022.00115

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

6413 39 8

Open Access Perspective

Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma

Sayuri Yoshikawa ... Satoru Matsuda

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:817–827

DOI: https://doi.org/10.37349/etat.2022.00114

This article belongs to the special issue Theranostic Frontiers in Neuro-Oncology

Full Text PDF

7883 1751 10

Open Access Review

Artificial intelligence in breast cancer imaging: risk stratification, lesion detection and classification, treatment planning and prognosis—a narrative review

Maurizio Cè ... Michaela Cellina

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:795–816

DOI: https://doi.org/10.37349/etat.2022.00113

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

10179 121 42

Open Access Review

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences

Marilia Barreca ... Francesco Bertoni

Published: December 26, 2022 Explor Target Antitumor Ther. 2022;3:763–794

DOI: https://doi.org/10.37349/etat.2022.00112

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

14221 94 29

Open Access Review

Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises

Mohamad Omar Ashi ... Stéphanie Corgnac

Published: December 22, 2022 Explor Target Antitumor Ther. 2022;3:746–762

DOI: https://doi.org/10.37349/etat.2022.00111

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

6948 73 5

Open Access Systematic Review

Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review

Maria Paola Belfiore ... Salvatore Cappabianca

Published: December 13, 2022 Explor Target Antitumor Ther. 2022;3:734–745

DOI: https://doi.org/10.37349/etat.2022.00110

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

8178 52 7

Open Access Review

Onosma L. as a source of anticancer agents: phytochemistry to mechanistic insight

Ajay Kumar ... Satwinderjeet Kaur

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:719–733

DOI: https://doi.org/10.37349/etat.2022.00109

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

5446 62 6

Open Access Review

The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors

Maria Teresa Palano ... Lorenzo Mortara

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:694–718

DOI: https://doi.org/10.37349/etat.2022.00108

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

7220 84 20

Open Access Review

Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers

Shiu Ying Tsao

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:676–693

DOI: https://doi.org/10.37349/etat.2022.00107

This article belongs to the special issue Theranostic Frontiers in Neuro-oncology

Full Text PDF

8096 27 2

Open Access Review

Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies

Matthew Goldman ... Stephan Quintin

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:659–675

DOI: https://doi.org/10.37349/etat.2022.00106

Full Text PDF

34554 184 30

Open Access Review

Potential role of resveratrol and its nano-formulation as anti-cancer agent

Akshay Kumar ... Dilpreet Singh

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:643–658

DOI: https://doi.org/10.37349/etat.2022.00105

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

10067 80 34

Open Access Review

Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment

Yoshiharu Sato

Published: October 31, 2022 Explor Target Antitumor Ther. 2022;3:630–642

DOI: https://doi.org/10.37349/etat.2022.00104

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

7178 47 24

Open Access Review

Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions

Jerome Thiery

Published: October 27, 2022 Explor Target Antitumor Ther. 2022;3:598–629

DOI: https://doi.org/10.37349/etat.2022.00103

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

13813 58 24

Open Access Original Article

Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples

Iolanda Capone ... Giancarlo Pruneri

Published: October 27, 2022 Explor Target Antitumor Ther. 2022;3:582–597

DOI: https://doi.org/10.37349/etat.2022.00102

This article belongs to the special issue Off-Label Drugs and -Omics Data in Cancer Treatment

Full Text PDF

7591 35 10

Open Access Commentary

A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options

Daniela Criscuolo ... Angela Celetti

Published: October 25, 2022 Explor Target Antitumor Ther. 2022;3:570–581

DOI: https://doi.org/10.37349/etat.2022.00101

Full Text PDF

13197 47 13

Open Access Original Article

N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas

Feng Yuan ... Chiyuan Ma

Published: September 30, 2022 Explor Target Antitumor Ther. 2022;3:553–569

DOI: https://doi.org/10.37349/etat.2022.00100

This article belongs to the special issue Theranostic Frontiers in Neuro-Oncology

Full Text PDF

4144 45 2